DNA sequence

Genomics is the study of the body’s genes, their functions and their influence on the growth, development and working of the body – using a variety of techniques to look at the body’s DNA and associated compounds.

The UK is recognised worldwide as a leader in genomics and the unique structure of the NHS is allowing us to deliver these advances at scale and pace for patient benefit.

The role of NHS England and NHS Improvement is to enable the NHS to harness the power of genomic medicine and science to improve the health of our population as part of our commitments in the NHS Long Term Plan. We are doing this through the NHS Genomic Medicine Service.

The NHS is a world-leading healthcare system in its use of cutting-edge genomic technologies. We deliver faster and more accurate diagnoses for inherited and acquired disease, personalise treatments and interventions so they are more effective and predict and prevent certain conditions before they develop.

Genomic Research

Find information on genomic research including the NHS Genomic Medicine Service Research Collaborative and the 100,000 Genomes Project

Personalised medicine

Providing better management of people’s health by moving away from a ‘one size fits all’ approach.

What is genomics?

Watch this short video from Health Education England’s Genomics Education Programme, which outlines what genomics is, and the ways it can improve patient care.

It also explores how genomics can track and treat infections like MRSA and tuberculosis (TB), improving and saving lives.

What does genomics mean for patients?

Jessica is one of the first children to receive a diagnosis from the 100,000 Genomes Project.

In this video from Genomics England, Jessica’s family talk about what it means to them, and how it will affect her treatment.

News and blogs

NHS England strikes deal on life-saving gene-therapy drug that can help babies with rare genetic disease move and walk

A life-saving drug that can enable mobility in babies and young children suffering from a rare genetic condition will be available on the NHS, chief executive Sir Simon Stevens announced today. Zolgensma, which has a reported list price of £1.79 million per dose and is labelled the most expensive drug in the world, will be […]